Ä¢¹½ÊÓÆµ

If you are a Healthfirst member and received a letter regarding negotiations with NewYork-Presbyterian,
read to find the latest information.

Franco Castillo Tokumori, M.D.

Hematology/Oncology
Insurances Accepted

For relevant information regarding accepted insurances, please contact this provider directly.

Personal Statement

As a hematologist, identifying gaps in patient care and translating laboratory findings back into the clinical setting proves to be tremendously rewarding. My primary career goal is to continually enhance our understanding of hematopoiesis, the process by which blood stem cells differentiate into mature, functional cells, both in normal conditions and in aberrant conditions, such as blood cancers. My research projects focus on developing novel methods to measure disease activity, enabling the accurate assessment of disease progression risk, and accelerating the development of treatment options for blood cancers, specifically in the context of myeloproliferative neoplasms —a chronic type of blood cancer characterized by abnormal hematopoiesis.

Biographical Info

Franco Castillo Tokumori, M.D., is an Instructor in Medicine within the Division of Hematology and Medical Oncology at Ä¢¹½ÊÓÆµ and Assistant Attending physician at NewYork-Presbyterian Hospital. Dr. Castillo Tokumori treats patients with various blood conditions, with a special interest in caring for those with myeloproliferative neoplasms (MPNs), which has been the primary focus of his research.

Dr. Castillo Tokumori received his M.D. from Universidad Peruana Cayetano Heredia in 2016. After graduating, he worked in his home university’s Pediatric Infectious Diseases Laboratory and completed a postgraduate Diploma in Immunology. He then completed his residency training in Internal Medicine (2022) at the University of South Florida, where he also served as chief resident. He completed his fellowship in Hematology and Medical Oncology (2025) at Ä¢¹½ÊÓÆµ and NewYork-Presbyterian (WCM/NYP). He is a physician-scientist working closely with the Richard T. Silver MD Myeloproliferative Neoplasm (MPN) Center and the Dr. Joseph Scandura Laboratory at Ä¢¹½ÊÓÆµ. Dr. Castillo Tokumori’s laboratory and clinical research is focused on developing new methods to measure disease activity in MPNs. His work in single-cell techniques to assess clonal dynamics in MPNs has been recognized by the American Society of Hematology (ASH) in the form of a career development grant.

Board Certifications
American Board of Internal Medicine
Languages
English
Spanish
Education 
  • M.D.
    Universidad Peruana Cayetano Heredia Faculty of Medicine (Peru)
    2016

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

No External Relationships Reported